850793-83-8Relevant articles and documents
Enantioselective Cyclopropanation/[1,5]-Hydrogen Shift to Access Rauhut-Currier Product
Kim, Seung Tae,Pandit, Rameshwar Prasad,Yun, Jaesook,Ryu, Do Hyun
supporting information, p. 213 - 217 (2021/01/09)
A Michael addition initiated cyclopropanation/[1,5]-hydrogen shift has been developed for the enantioselective synthesis of Rauhut-Currier products. The reaction of α-alkyl diazoesters and in situ generated o-quinone methides proceeds in the presence of c
PHENOXYETHER DERIVATIVES AS PPAR MODULATORS
-
Page/Page column 126, (2008/06/13)
The present invention is directed to a compound of formula (I), or a pharmaceutically acceptable salt, solvate, hydrate or stereoisomer thereof, which is useful in treating or preventing disorders mediated by a peroxisome proliferator activated receptor (PPAR), such as syndrome X, type II diabetes, hyperglycemia, hyperlipidemia, obesity, coagaulopathy, hypertension, arteriosclerosis, and other disorders related to syndrome X and cardiovascular diseases.